Prescripción potencialmente inapropiada en adultos mayores en México
OBJETIVE: To identify and quantify potentially inappropriate prescribing (prescripción potencialmente inapropiada, PPI) and other drug prescribing problems in public health care services in a population-based study at the three existing levels of complexity in Mexico. METHODS Descriptive analysis of...
| Authors: | , , , , , , |
|---|---|
| Format: | article |
| Status: | Published version |
| Publication Date: | 2021 |
| Country: | Brasil |
| Institution: | Universidade de São Paulo (USP) |
| Repository: | Revista de Saúde Pública |
| Language: | Spanish English |
| OAI Identifier: | oai:revistas.usp.br:article/193668 |
| Online Access: | https://www.revistas.usp.br/rsp/article/view/193668 |
| Access Level: | Open access |
| Keyword: | Old person Inappropriate Prescribing Comorbidity Misuse of Prescription Drugs Medication-Related Side Effects and Adverse Reactions Anciano Prescripción Inadecuada Comorbilidad Mal Uso de Medicamentos de Venta con Receta Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos |
| Summary: | OBJETIVE: To identify and quantify potentially inappropriate prescribing (prescripción potencialmente inapropiada, PPI) and other drug prescribing problems in public health care services in a population-based study at the three existing levels of complexity in Mexico. METHODS Descriptive analysis of the Study on Satisfaction of Users of the Social Protection System in Health 2014–2016, prescription and drug supply section, to obtain the prevalence of PPI in older adults (≥ 65 years), based on Beers, STOPP, Prescrire and BSP listings using AM (older adults) prescription indicators, one for each listing. RESULTS Most older adults (67%) were prescribed at least one medication, with a mean of 2.7 medications per prescription. The PPI prevalence was 74% according to the BSP criteria, 67% according to the STOPP listing, 59% with the Beer criteria, and 20% with Prescrire. The most frequent PPI prescriptions were NSAIDs, vasodilators and sulfonylureas. CONCLUSIONS The use of PPIs in AM is high in Mexico. The higher prevalence found in this study may reflect the use of a source with population representativeness. The partial use and adaptations of the criteria make difficult comparing the studies; however, the STOPP criteria are the ones with the highest prevalence, as they cover a greater number of drugs and their use is more common in the first level of care. |
|---|